FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Exciting Times Ahead for TRIMTECH Therapeutics with $31M Seed Funding
The investment will support further development of TRIMTECH Therapeutics growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
The oversubscribed round was led by new investor HealthQuest Capital with support from existing OrganOx investors BGF and Lauxera Capital Partners, along with additional new investors Sofina, Soleus Capital, and Avidity Partners.
Advancing Eye Health: Perceive Pharma Secures $15M Investment Boost
In addition, Perceive Pharma announced that Carol Gallagher, Pharm.D. has joined the company's Board of Directors as an independent director.
Exero Medical Closes on $12.7M Preferred Seed Financing
This financing includes investments from new investors Longevity Venture Partners, Tech Council Ventures, and Edge Medical Ventures, alongside participation from existing investors notes Exero Medical.
REEV Raises $9.2M | To Revolutionize Mobility Assistance for Patients with Gait Disorders
"With the support of our world-class partners, we are thrilled to enter the next phase of clinical and industrial development," said Amaury Ciurana, Co-Founder and CEO of REEV. "Our innovative technologies, like the DREEVEN motorized orthosis, aim to redefine mobility assistance, transforming lives and reshaping the orthotics industry."
Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
Glox Therapeutics will receive up to £500,000 of the fund to accelerate the development of its novel precision antibiotics, helping to address the growing need for effective treatments to overcome antimicrobial-resistant lung infections in people with cystic fibrosis.
Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders
“We look forward to partnering with Caidya’s management team and existing investors to support the company’s continued growth plans as a leading global CRO,” said Glaccum. “As both investors and operators in the global healthcare and pharmaceutical services industries, we are excited to bring our expertise to support Caidya’s mission to advance the future of healthcare by providing patients around the world with access to novel therapies.”
Cytomos Secures £5M | To Scale Up Production of Cell-analysis Technology
New investment will allow Cytomos to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction.
TactoTek Secures $60 Million in Funding Led by Virala Group
With this funding, TactoTek will accelerate the adoption of IMSE globally by expanding customer-facing operations and streamlining IMSE solution design by augmenting our software-based delivery system with AI elements and plug-ins for CAD and simulation packages
Medical Device News Magazine